Home » Topics » Regulatory » Patents

Patents
RSS

BioCryst Pharmaceuticals divulges complement factor D inhibitors

Aug. 29, 2017

Epizyme patents PRMT inhibitors

Aug. 29, 2017

Roche discloses new DDR1 inhibitors

Aug. 28, 2017

AstraZeneca AB and Eolas Therapeutics patent orexin receptor antagonists

Aug. 28, 2017

Shenzhen Targetrx Biotechnology divulges novel CYP17A1 inhibitors

Aug. 28, 2017

Fochon Pharma and collaborators present ALK inhibitors

Aug. 28, 2017

Yangtze River Pharmaceutical Group and collaborator patent Nav1.7 channel blockers

Aug. 28, 2017

EA Pharma divulges new TRPA1 antagonists

Aug. 25, 2017

Savira, European Molecular Biology Laboratory discover novel compounds for influenza

Aug. 25, 2017

GPCR19 agonists patented by Universite de Droit et Sante de Lille, Institut Pasteur de Lille, INSERM

Aug. 25, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...